HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

4- ((3- bromophenyl)amino)- 6,7- dimethoxyquinazoline

structure given in first source
Also Known As:
EBE-A22; N-(3-bromophenyl)-6,7-dimethoxy-4-quinazolinamine; PD 153035; PD-153035; PD153035
Networked: 43 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Steinbach, Joachim P: 3 articles (10/2020 - 03/2004)
2. Wells, Alan: 2 articles (11/2012 - 01/2012)
3. Franchini, Kleber G: 2 articles (05/2010 - 12/2009)
4. Rittner, Roberto: 2 articles (05/2010 - 12/2009)
5. Rocco, Silvana A: 2 articles (05/2010 - 12/2009)
6. Di, Wen: 2 articles (08/2008 - 09/2005)
7. Wan, Yinsheng: 2 articles (08/2008 - 09/2005)
8. Grunt, Thomas W: 2 articles (11/2007 - 04/2005)
9. Puckmair, Klaudia: 2 articles (11/2007 - 04/2005)
10. Tomek, Katharina: 2 articles (11/2007 - 04/2005)

Related Diseases

1. Ischemia
2. Neoplasms (Cancer)
3. Malignant Mesothelioma
4. Prostatic Neoplasms (Prostate Cancer)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. anilinoquinazoline
2. ErbB Receptors (EGF Receptor)
3. Tyrosine Kinase Inhibitors
4. Epidermal Growth Factor (EGF)
5. Protein-Tyrosine Kinases (Tyrosine Kinase)
6. Phosphotransferases (Kinase)
7. Ligands
8. Glucose (Dextrose)
9. Gefitinib (Iressa)
10. Erlotinib Hydrochloride (CP 358,774)

Related Therapies and Procedures

1. Intravenous Administration
2. Intravenous Injections
3. Drug Therapy (Chemotherapy)
4. Aftercare (After-Treatment)